Medicinally used Asarum species: High-resolution LC-MS analysis of aristolochic acid analogs and in vitro toxicity screening in HK-2 cells

Frontiers in Pharmacology

Volumn 8, Issue MAY, 2017, Pages

  Michl, Johanna ^a   Bello, Olusheyi ^a   Kite, Geoffrey C ^b   Simmonds, Monique S J ^b   Heinrich, Michael ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL BOTANIC GARDENS   (United Kingdom)

Author keywords

Aristolactam; Asarum; LC MS; Metabolomics; Nephrotoxicity

Indexed keywords

7 METHOXY ARISTOLACTAM IV; 9 METHOXY ARISTOLACTAM IV; ARISTOFOLIN A; ARISTOLACTAM BII; ARISTOLACTAM CIII; ARISTOLACTAM I; ARISTOLACTAM II; ARISTOLACTAM IV; ARISTOLACTAM VII; ARISTOLOCHIC ACID D; ARISTOLOCHIC ACID DERIVATIVE; ARISTOLOCHIC ACID E; ARISTOLOCHIC ACID I; ARISTOLOCHIC ACID IIIA; ARISTOLOCHIN; ASARUM EXTRACT; METHANOL; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; WATER;

ARTICLE; ASARUM; CARCINOGENICITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; METABOLOMICS; NEPHROTOXICITY; TOXICITY TESTING;

EID: 85019581153     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2017.00215     Document Type: Article

References (34)

1. Achenbach, H., and Fischer, A. (1997). Aristolochic acids and aristolactams from the seeds of Aristolochia baetica. Planta Med. 63:387. doi: 10.1055/s-2006-957716
2. Arlt, V. M., Zuo, J., Trenz, K., Roufosse, C. A., Lord, G. M., Nortier, J. L., et al. (2011). Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice. Int. J. Cancer 128, 21-32. doi: 10.1002/ijc.25324
3. Balachandran, P., Wei, F., Lin, R. C., Khan, I. A., and Pasco, D. S. (2005). Structure activity relationships of aristolochic acid analogues: toxicity in cultured renal epithelial cells. Kidney Int. 67, 1797-1805. doi: 10.1111/j.1523-1755.2005.00277.x
4. Chan, S. A., Chen, M. J., Liu, T. Y., Fuh, M. R., Deng, J. F., Wu, M. L., et al. (2003). Determination of aristolochic acids in medicinal plant and herbal product by liquid chromatography-electrospray-ion trap mass spectrometry. Talanta 60, 679-685. doi: 10.1016/S0039-9140(03)00142-5
5. Chan, W., Hui, K. M., Poon, W. T., Lee, K. C., and Cai, Z. (2006). Differentiation of herbs linked to Chinese herb nephropathy from the liquid chromatographic determination of aristolochic acids. Anal. Chim. Acta 576, 112-116. doi: 10.1016/j.aca.2006.03.008
6. Chen, C. H., Dickman, K. G., Moriya, M., Zavadil, J., Sidorenko, V. S., Edwards, K. L., et al. (2012). Aristolochic acid-associated urothelial cancer in Taiwan. Proc. Natl. Acad. Sci. U.S.A. 109, 8241-8246. doi: 10.1073/pnas.1119920109
7. Grollman, A. P. (2013). Aristolochic acid nephropathy: harbinger of a global iatrogenic disease. Environ. Mol. Mutagen. 54, 1-7. doi: 10.1002/em.21756
8. Hashimoto, K., Higuchi, M., Makino, B., Sakakibara, I., Kubo, M., Komatsu, Y., et al. (1999). Quantitative analysis of aristolochic acids, toxic compounds, contained in some medicinal plants. J. Ethnopharmacol. 64, 185-189. doi: 10.1016/S0378-8741(98)00123-8
9. Houghton, P., Fang, R., Techatanawat, I., Steventon, G., Hylands, P. J., and Lee, C. C. (2007). The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity. Methods 42, 377-387. doi: 10.1016/j.ymeth.2007.01.003
10. Hsu, Y.-H., Lo, C.-F., Liu, F.-S., and Lin, J.-H. (2009). Analysis of aristolochic acid in Asarum (Xixin) and its preparations by liquid chromatography/tandem mass spectrometry. J. Food Drug Anal. 17, 274-281. Available online at: http://web.a.ebscohost.com/abstract?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=10219498&AN=46981093&h=s11ZNjpsLF3VcGPa%2bs1QeW3eiJ3G9YvzLRqNrDiYIhyBhKPqiQRBBWdhknJdVzq%2fgHVqwWYj0tXOOR1vGHws4Q%3d%3d&crl=c&resultNs=AdminWebAuth&resultLocal=ErrCrlNotAuth&crlhashurl=login.aspx%3fdirect%3dtrue%26profile%3dehost%26scope%3dsite%26authtype%3dcrawler%26jrnl%3d10219498%26AN%3d46981093
11. Hu, S. L., Zhang, H. Q., Chan, K., and Mei, Q. X. (2004). Studies on the toxicity of Aristolochia manshuriensis (Guanmuton). Toxicology 198, 195-201. doi: 10.1016/j.tox.2004.01.026
12. Iwashina, T., and Kitajima, J. (2000). Chalcone and flavonol glycosides from Asarum canadense (Aristolochiaceae). Phytochemistry 55, 971-974. doi: 10.1016/S0031-9422(00)00216-8
13. Jaspersen-Schib, R., Theus, L., Guirguis-Oeschger, M., Gossweiler, B., and Meier-Abt, P. J. (1996). Serious plant poisonings in Switzerland 1966-1994. Case analysis from the Swiss toxicology information center. Schweiz. Med. Wochenschr. 126, 1085-1098
14. Jelakovic, B., Karanovic, S., Vukovic-Lela, I., Miller, F., Edwards, K. L., Nikolic, J., et al. (2012). Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int. 81, 559-567. doi: 10.1038/ki.2011.371
15. Jong, T. T., Lee, M. R., Hsiao, S. S., Hsai, J. L., Wu, T. S., Chiang, S. T., et al. (2003). Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/atmospheric pressure chemical ionization/tandem mass spectrometry. J. Pharm. Biomed. Anal. 33, 831-837. doi: 10.1016/S0731-7085(03)00310-8
16. Kim, E. J., Chen, Y., Huang, J. Q., Li, K. M., Razmovski-Naumovski, V., Poon, J., et al. (2013). Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines. J. Ethnopharmacol. 146, 40-61. doi: 10.1016/j.jep.2012.12.027
17. Kumar, V., Poonam, Prasad, A. K., and Parmar, V. S. (2003). Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities. Nat. Prod. Rep. 20, 565-583. doi: 10.1039/b303648k
18. Li, B., Li, X. M., Zhang, C. Y., Wang, X., and Cai, S. Q. (2004). Cellular mechanism of renal proximal tubular empithelial cell injury induced by aristolochic acid I and aristololactam I. Beijing Da Xue Xue Bao 36, 36-40
19. Mengs, U. (1988). Tumour induction in mice following exposure to aristolochic acid. Arch. Toxicol. 61, 504-505. doi: 10.1007/BF00293699
20. Michl, J., Ingrouille, M. J., Simmonds, M. S., and Heinrich, M. (2014). Naturally occurring aristolochic acid analogues and their toxicities. Nat. Prod. Rep. 31, 676-693. doi: 10.1039/c3np70114j
21. Michl, J., Kite, G. C., Wanke, S., Zierau, O., Vollmer, G., Neinhuis, C., et al. (2016). LC-MS-and 1H NMR-based metabolomic analysis and in vitro toxicological assessment of 43 Aristolochia species. J. Nat. Prod. 79, 30-37. doi: 10.1021/acs.jnatprod.5b00556
22. Mix, D. B., Guinaudeau, H., and Shamma, M. (1982). The aristolochic acids and aristolactams. J. Nat. Prod. 45, 657-666. doi: 10.1021/np50024a001
23. Moermon, D. (2017). Native American Ethnobotany DB. Available online at: http://naeb.brit.org
24. Nitzsche, D., Melzig, M. F., and Arlt, V. M. (2013). Evaluation of the cytotoxicity and genotoxicity of aristolochic acid I-a component of Aristolochiaceae plant extracts used in homeopathy. Environ. Toxicol. Pharmacol. 35, 325-334. doi: 10.1016/j.etap.2013.01.007
25. Nortier, J. L., Martinez, M. C., Schmeiser, H. H., Arlt, V. M., Bieler, C. A., Petein, M., et al. (2000). Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). New Engl. J. Med. 342, 1686-1692. doi: 10.1056/NEJM200006083422301
26. Quang, T. H., Ngan, N. T., Minh, C. V., Kiem, P. V., Tai, B. H., Thao, N. P., et al. (2012). Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii. Bioorg. Med. Chem. Lett. 22, 2527-2533. doi: 10.1016/j.bmcl.2012.01.136
27. Wen, H., Gao, H. Y., Qi, W., Xiao, F., Wang, L. L., Wang, D., et al. (2014). Simultaneous determination of twenty-two components in Asari Radix et Rhizoma by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Planta Med. 80, 1753-1762. doi: 10.1055/s-0034-1383296
28. Wen, Y. J., Su, T., Tang, J. W., Zhang, C. Y., Wang, X., Cai, S. Q., et al. (2006). Cytotoxicity of phenanthrenes extracted from Aristolochia contorta in human proximal tubular epithelial cell line. Nephron. Exp. Nephrol. 103, e95-e102. doi: 10.1159/000092194
29. Yang, H., Dou, Y., Zheng, X., Tan, Y., Cheng, J., Li, L., et al. (2011). Cysteinyl leukotrienes synthesis is involved in aristolochic acid I-induced apoptosis in renal proximal tubular epithelial cells. Toxicology 287, 38-45. doi: 10.1016/j.tox.2011.05.014
30. Yang, H. Y., Lin, J. L., Chen, K. H., Yu, C. C., Hsu, P. Y., and Lin, C. L. (2006). Aristolochic acid-related nephropathy associated with the popular Chinese herb Xi Xin. J. Nephrol. 19, 111-114
31. Yuan, J., Liu, Q., Wei, G., Tang, F., Ding, L., and Yao, S. (2007). Characterization and determination of six aristolochic acids and three aristololactams in medicinal plants and their preparations by high-performance liquid chromatography-photodiode array detection/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 21, 2332-2342. doi: 10.1002/rcm.3097
32. Yuan, J., Liu, Q., Zhu, W., Ding, L., Tang, F., and Yao, S. (2008). Simultaneous analysis of six aristolochic acids and five aristolactams in herbal plants and their preparations by high-performance liquid chromatography-diode array detection-fluorescence detection. J. Chromatogr. A 1182, 85-92. doi: 10.1016/j.chroma.2007.12.076
33. Zhang, F., Chu, C. H., Xu, Q., Fu, S. P., Hu, J. H., Xiao, H. B., et al. (2005). A new amide from Asarum forbesii Maxim. J. Asian Nat. Prod. Res. 7, 1-5. doi: 10.1080/10286020310001596015
34. Zhao, Z. Z., Liang, Z. T., Jiang, Z. H., Leung, K. S., Chan, C. L., Chan, H. Y., et al. (2008). Comparative study on the aristolochic acid I content of Herba Asarifor safe use. Phytomedicine 15, 741-748. doi: 10.1016/j.phymed.2008.06.006